Dechène M, Leying H, Cullmann W
Department of Medical Microbiology and Immunology, Ruhr University, Bochum, FRG.
Chemotherapy. 1990;36(1):13-23. doi: 10.1159/000238743.
Quinolone-resistant clones were selected from clinical Escherichia coli, Citrobacter freundii and Serratia marcescens isolates in a frequency ranging from 10(-8) to 10(-6). The outer membrane proteins of quinolone-resistant E. coli clones remained unaltered, as was the case for 10 of 11 C. freundii and 4 of 11 S. marcescens clones ('nal B' type). There was no strong relation between alterations of outer membrane proteins and cross-resistance with chemically unrelated compounds such as tetracycline or chloramphenicol; however, tetracycline resistance was observed in some C. freundii clones with unaltered outer membrane proteins ('mar A'). Most of the quinolone-resistant S. marcescens clones can be considered 'nor B' or 'nor C' mutants due to their cross-resistance with other compounds, their altered outer membrane proteins and changes of lipopolysaccharide. In a few cases, subinhibitory quinolone concentrations caused alterations of outer membrane proteins in S. marcescens during mid log phase without development of resistance.
从临床分离的大肠杆菌、弗氏柠檬酸杆菌和粘质沙雷氏菌中筛选出喹诺酮抗性克隆,其频率范围为10^(-8)至10^(-6)。喹诺酮抗性大肠杆菌克隆的外膜蛋白保持不变,11株弗氏柠檬酸杆菌中有10株以及11株粘质沙雷氏菌中有4株(“nal B”型)也是如此。外膜蛋白的改变与对化学结构不相关的化合物(如四环素或氯霉素)的交叉抗性之间没有密切关系;然而,在一些外膜蛋白未改变的弗氏柠檬酸杆菌克隆(“mar A”)中观察到了四环素抗性。由于大多数喹诺酮抗性粘质沙雷氏菌克隆与其他化合物存在交叉抗性、外膜蛋白发生改变以及脂多糖发生变化,因此可被视为“nor B”或“nor C”突变体。在少数情况下,亚抑菌浓度的喹诺酮在对数中期会导致粘质沙雷氏菌外膜蛋白发生改变,但不会产生抗性。